{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:10:53Z","timestamp":1791461453743,"version":"4.3.4"},"reference-count":107,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>Hepatitis C virus (HCV) infection is a growing international health problem, and more than 170 million people are chronic carriers. Up to 50% of HCV-positive patients develop at least one extrahepatic manifestation during the course of disease. To varying degrees of certainty, there is evidence of an association between chronic HCV infection and a variety of neuromuscular diseases. The pathogenesis of most extrahepatic diseases remains unclear but possibly includes HCV lymphotropism and\/or HCV-induced autoantibodies. The therapeutic approach to HCV-associated autoimmune disorders entails eradication of HCV with one of the recombinant interferon-alpha preparations with or without additional immunosuppressive drugs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cnd.0b013e3181d4a527","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T19:51:21Z","timestamp":1317757881000},"page":"14-25","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Neuromuscular Diseases Associated With Chronic Hepatitis C Virus Infection"],"prefix":"10.1097","volume":"13","author":[{"given":"Joerg-Patrick","family":"St\u00fcbgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20240808","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","article-title":"Pathogenesis, natural history, treatment, and prevention of hepatitis C.","volume":"132","author":"Liang","year":"2000","journal-title":"Ann Intern Med"},{"key":"R2-2-20240808","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection.","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"R3-2-20240808","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jhep.2003.10.009","article-title":"Extrahepatic disease manifestations of HCV infection: some current issues.","volume":"40","author":"Agnello","year":"2004","journal-title":"J Hepatol"},{"key":"R4-2-20240808","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/B:MEBR.0000043982.17294.9b","article-title":"Hepatitis C virus-associated extrahepatic manifestations: a review.","volume":"19","author":"Sene","year":"2004","journal-title":"Metab Brain Dis"},{"key":"R5-2-20240808","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-3-25","article-title":"Mixed cryoglobulinemia.","volume":"3","author":"Ferri","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"R6-2-20240808","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005792-199401000-00005","article-title":"Mixed cryoglobulinemia in chronic hepatitis C infection: a clinicopathologic analysis of 10 cases and review of recent literature.","volume":"73","author":"Levey","year":"1994","journal-title":"Medicine"},{"key":"R7-2-20240808","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2249.1996.d01-639.x","article-title":"Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection.","volume":"104","author":"Wong","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"R8-2-20240808","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.","volume":"42","author":"Cacoub","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R9-2-20240808","first-page":"447","article-title":"Extrahepatic manifestations in patients with chronic hepatitis C virus infection.","volume":"17","author":"Ramos-Casals","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"R10-2-20240808","first-page":"613","article-title":"High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.","volume":"21","author":"Clifford","year":"1995","journal-title":"Hepatology"},{"key":"R11-2-20240808","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000171594","article-title":"Extrahepatic immunological features of chronic viral hepatitis.","volume":"15","author":"Czaja","year":"1997","journal-title":"Dig Dis Sci"},{"key":"R12-2-20240808","first-page":"75","article-title":"Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions.","volume":"17","author":"Valentini","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"R13-2-20240808","first-page":"120","article-title":"Hepatitis C virus, autoimmunity and lymphoproliferation.","volume":"67","author":"Eng","year":"2000","journal-title":"Mt Sinai J Med"},{"key":"R14-2-20240808","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0889-857X(05)70013-2","article-title":"Hepatitis C-associated autoimmune disorders.","volume":"24","author":"McMurray","year":"1998","journal-title":"Rheum Dis Clin North Am"},{"issue":"Suppl 1","key":"R15-2-20240808","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S1590-8658(07)80006-5","article-title":"Hepatitis C and autoreactivity.","volume":"39","author":"Bianchi","year":"2007","journal-title":"Dig Liver Dis"},{"key":"R16-2-20240808","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11894-006-0064-y","article-title":"Extrahepatic manifestations of hepatitis C virus.","volume":"8","author":"Sterling","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"key":"R17-2-20240808","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/jnnp.2005.081570","article-title":"Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population.","volume":"77","author":"Santoro","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R18-2-20240808","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC Groupe dEtude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de lHepatite C.","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine"},{"key":"R19-2-20240808","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00131402-200303000-00002","article-title":"Prevalence and risk factors associated with the presence of peripheral neuropathy in patients with hepatitis C virus infection.","volume":"4","author":"Tellez-Zenteno","year":"2003","journal-title":"J Clin Neuromusc Dis"},{"key":"R20-2-20240808","first-page":"391","article-title":"High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinemia.","volume":"30","author":"Zaltron","year":"1998","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"R21-2-20240808","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1590\/S0004-282X2006000400014","article-title":"Peripheral neuropathy in patients with hepatitis virus C infection in the Amazon region.","volume":"64","author":"Gomes","year":"2006","journal-title":"Arq Neuropsiquiatr"},{"key":"R22-2-20240808","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jnnp.60.6.661","article-title":"Peripheral neuropathy associated with essential cryoglobulinemia: a role for hepatitis C virus infection?","volume":"60","author":"Apartis","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R23-2-20240808","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.410340524","article-title":"High incidence of hepatitis C virus infection in patients with cryoglobulinemic neuropathy.","volume":"34","author":"Authier","year":"1993","journal-title":"Ann Neurol"},{"key":"R24-2-20240808","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archneur.1988.00520350048015","article-title":"Peripheral neuropathy in essential mixed cryoglobulinemia.","volume":"45","author":"Garcia-Bragado","year":"1988","journal-title":"Arch Neurol"},{"key":"R25-2-20240808","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/jnnp.55.2.116","article-title":"Peripheral neuropathy in essential mixed cryoglobulinemia.","volume":"55","author":"Gemignani","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R26-2-20240808","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/jnnp.74.9.1267","article-title":"Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinemia.","volume":"74","author":"Nemni","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R27-2-20240808","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mus.10260","article-title":"Viral RNA in nerve tissue of patients with hepatitis C infection and peripheral neuropathy.","volume":"27","author":"De Martino","year":"2003","journal-title":"Muscle Nerve"},{"key":"R28-2-20240808","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/ard.60.3.290","article-title":"Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinemia.","volume":"60","author":"Lidove","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R29-2-20240808","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0248-8663(01)00452-0","article-title":"Peripheral neuropathy and hepatitis C virus infection: more than cryoglobulinemia.","volume":"22","author":"Lidove","year":"2001","journal-title":"Rev Med Interne"},{"key":"R30-2-20240808","first-page":"175","article-title":"Peripheral neuropathy without cryoglobulinemia in patients with hepatitis C virus infection.","volume":"42","author":"Paoletti","year":"2000","journal-title":"Panminerva Med"},{"key":"R31-2-20240808","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0035-3787(06)75056-1","article-title":"The presentation of viral hepatitis C infection without cryoglobulinemia with peripheral neuropathy. Five case reports.","volume":"162","author":"Rafai","year":"2006","journal-title":"Rev Neurol"},{"key":"R32-2-20240808","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1212\/01.WNL.0000044399.71601.EA","article-title":"Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy.","volume":"60","author":"Authier","year":"2003","journal-title":"Neurology"},{"key":"R33-2-20240808","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/(SICI)1097-4598(199612)19:12<1596::AID-MUS9>3.0.CO;2-5","article-title":"Nonsystemic vasculitic mononeuropathy multiplex, cryoglobulinemia, and hepatitis C.","volume":"19","author":"David","year":"1996","journal-title":"Muscle Nerve"},{"key":"R34-2-20240808","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2169\/internalmedicine.42.394","article-title":"Peripheral neuropathy in Japanese patients with hepatitis C virus infection.","volume":"42","author":"Ijichi","year":"2003","journal-title":"Intern Med"},{"key":"R35-2-20240808","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1212\/WNL.53.4.861","article-title":"Neurologic complications associated with hepatitis C virus infection.","volume":"53","author":"Tembl","year":"1999","journal-title":"Neurology"},{"key":"R36-2-20240808","first-page":"109","article-title":"Systemic vasculitis in patients with hepatitis C.","volume":"28","author":"Cacoub","year":"2001","journal-title":"J Rheumatol"},{"key":"R37-2-20240808","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0676.1998.tb00126.x","article-title":"Hepatitis C associated with Guillain-Barre syndrome.","volume":"18","author":"Lacaille","year":"1998","journal-title":"Liver"},{"key":"R38-2-20240808","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2169\/internalmedicine.39.397","article-title":"Membranoproliferative glomerulonephritis and demyelinating neuropathy caused by type II cryoglobulinemia associated with HCV infection.","volume":"39","author":"Suzuki","year":"2000","journal-title":"Intern Med"},{"key":"R39-2-20240808","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1468-1331.2003.00560.x","article-title":"Motor-axonal neuropathy associated with hepatitis C virus.","volume":"10","author":"Costa","year":"2003","journal-title":"Eur J Neurol"},{"key":"R40-2-20240808","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-5728(96)00191-9","article-title":"T-cell-mediated epineural vasculitis and humeral-mediated microangiopathy in cryoglobulinemic neuropathy.","volume":"73","author":"Bonetti","year":"1997","journal-title":"J Neuroimmunol"},{"key":"R41-2-20240808","first-page":"26","article-title":"Peripheral nervous system involvement in HCV-related mixed cryoglobulinemia.","volume":"53","author":"Migliaresi","year":"2001","journal-title":"Reumatismo"},{"key":"R42-2-20240808","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s004280050380","article-title":"Hepatitis C virus infection of peripheral nerves in type II cryoglobulinemia.","volume":"434","author":"Bonetti","year":"1999","journal-title":"Virchows Arch"},{"key":"R43-2-20240808","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1212\/WNL.32.7.725","article-title":"The pathogenesis of cryoglobulinemic neuropathy.","volume":"32","author":"Chad","year":"1982","journal-title":"Neurology"},{"key":"R44-2-20240808","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/mus.880150805","article-title":"Vasculitic neuropathy in a patient with cryoglobulinemia and anti-MAG IgM monoclonal gammopathy.","volume":"15","author":"Thomas","year":"1992","journal-title":"Muscle Nerve"},{"key":"R45-2-20240808","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia.","volume":"327","author":"Agnello","year":"1992","journal-title":"N Engl J Med"},{"key":"R46-2-20240808","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","article-title":"Randomized trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT).","volume":"352","author":"Poynard","year":"1998","journal-title":"Lancet"},{"key":"R47-2-20240808","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis International Therapy Group.","volume":"339","author":"McHutchison","year":"1998","journal-title":"N Engl J Med"},{"key":"R48-2-20240808","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/art.10699","article-title":"Interferon-alpha and ribavirin treatment in patients with hepatitis C-related systemic vasculitis.","volume":"46","author":"Cacoub","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R49-2-20240808","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/mus.20184","article-title":"Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study.","volume":"31","author":"Ammendola","year":"2005","journal-title":"Muscle Nerve"},{"key":"R50-2-20240808","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","article-title":"Interferon-alpha in mixed cryoglobulinemia patients: randomized, crossover-controlled trial.","volume":"81","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"R51-2-20240808","first-page":"2466","article-title":"Longterm efficacy of interferon-alpha for extrahepatic disease with hepatitis C infection.","volume":"28","author":"Naarendorp","year":"2001","journal-title":"J Rheumatol"},{"key":"R52-2-20240808","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2004.10.031","article-title":"Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study.","volume":"42","author":"Mazzaro","year":"2005","journal-title":"J Hepatol"},{"key":"R53-2-20240808","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","article-title":"Pegylated interferon alpha-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.","volume":"52","author":"Cacoub","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R54-2-20240808","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis.","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R55-2-20240808","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon with an anti-CD20.","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"R56-2-20240808","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia.","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"R57-2-20240808","first-page":"1197","article-title":"Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab.","volume":"33","author":"Cai","year":"2006","journal-title":"J Rheumatol"},{"key":"R58-2-20240808","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/ard.2002.004929","article-title":"Rituximab induces remission in refractory HCV associated cryoglobulinemic vasculitis.","volume":"62","author":"Lamprecht","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R59-2-20240808","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2893.1996.tb00106.x","article-title":"Myasthenia gravis and hepatitis C virus infection.","volume":"3","author":"Halfon","year":"1996","journal-title":"J Viral Hepatol"},{"key":"R60-2-20240808","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jnnp.64.6.820","article-title":"Untreated hepatitis C may provoke myasthenia gravis.","volume":"64","author":"Reading","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R61-2-20240808","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1023\/A:1026683007277","article-title":"Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection.","volume":"44","author":"Eddy","year":"1999","journal-title":"Dig Dis Sci"},{"key":"R62-2-20240808","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0049-0172(98)80043-7","article-title":"Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus-infected Israeli patients.","volume":"28","author":"Buskila","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"R63-2-20240808","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0248-8663(00)89230-9","article-title":"Association between polymyositis and hepatitis C infection. Treatment-related difficulties.","volume":"21","author":"Alric","year":"2000","journal-title":"Rev Med Interne"},{"key":"R64-2-20240808","first-page":"1584","article-title":"Dermatomyositis following infection with hepatitis C virus.","volume":"21","author":"Nishikai","year":"1994","journal-title":"J Rheumatol"},{"key":"R65-2-20240808","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/1529-0131(199807)41:7<1323::AID-ART26>3.0.CO;2-G","article-title":"Inflammatory myopathy and hepatitis C virus infection.","volume":"41","author":"Monger","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R66-2-20240808","first-page":"208","article-title":"Clinical characteristics and muscle histopathology in polymyositis positive anti-hepatitis with C virus antibody.","volume":"37","author":"Ayabe","year":"1997","journal-title":"Rinsho Shinkeigaku"},{"key":"R67-2-20240808","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00124743-200202000-00010","article-title":"Hepatitis C virus infection, inflammatory myopathy, and pulmonary fibrosis: are they related?","volume":"8","author":"Agha","year":"2002","journal-title":"J Clin Rheumatol"},{"key":"R68-2-20240808","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2169\/internalmedicine.40.1109","article-title":"Polymyositis, pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection.","volume":"40","author":"Aisa","year":"2001","journal-title":"Intern Med"},{"key":"R69-2-20240808","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00124743-199608000-00017","article-title":"Treatment with alpha-interferon for hepatitis C infection in a patient with polymyositis.","volume":"2","author":"Blasini","year":"1996","journal-title":"J Clin Rheumatol"},{"key":"R70-2-20240808","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.1780390634","article-title":"Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection.","volume":"39","author":"Ferri","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R71-2-20240808","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0928-4346(95)00245-6","article-title":"Inflammatory myopathy associated with hepatitis C virus infection: a report of 4 cases.","volume":"4","author":"Harada","year":"1995","journal-title":"Int Hepatol Commun"},{"key":"R72-2-20240808","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(95)92016-1","article-title":"Symptomatic myopathy in hepatitis C infection without interferon therapy.","volume":"345","author":"Horsmans","year":"1995","journal-title":"Lancet"},{"key":"R73-2-20240808","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1212\/01.WNL.0000154605.02737.FE","article-title":"In situ identification of hepatitis C virus RNA in muscle.","volume":"64","author":"Ito","year":"2005","journal-title":"Neurology"},{"key":"R74-2-20240808","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10067-004-1020-6","article-title":"Marked increase in serum hepatitis C virus (HCV) RNA titer during treatment with high-dose prednisolone in a case of polymyositis.","volume":"24","author":"Kato","year":"2005","journal-title":"Clin Rheumatol"},{"key":"R75-2-20240808","first-page":"429","article-title":"Development of myositis after hepatitis C virus infection.","volume":"23","author":"Mercado","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"R76-2-20240808","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510340439","article-title":"Inflammatory myopathy and hepatitis C in a pediatric patient: role of liver biopsy in evaluating the severity of liver disease.","volume":"34","author":"Mohan","year":"2001","journal-title":"Hepatology"},{"key":"R77-2-20240808","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(95)92211-3","article-title":"Hepatitis C infection and polymyositis.","volume":"346","author":"Ueno","year":"1995","journal-title":"Lancet"},{"key":"R78-2-20240808","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/PL00007437","article-title":"Hepatitis C virus infection and myositis: a polymerase chain reaction study.","volume":"99","author":"Villanova","year":"2000","journal-title":"Acta Neuropathol"},{"key":"R79-2-20240808","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/art.1780380324","article-title":"Polymyositis, pulmonary fibrosis, and hepatitis C.","volume":"3","author":"Weidensaul","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R80-2-20240808","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0960-8966(02)00184-0","article-title":"Hepatitis C virus infection and myositis: a virus localization study.","volume":"13","author":"Di Muzio","year":"2003","journal-title":"Neuromusc Disord"},{"key":"R81-2-20240808","first-page":"197","article-title":"HCV and dermatomyositis: report of 5 cases of dermatomyositis in patients with HCV infection.","volume":"18","author":"Fiore","year":"1996","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"R82-2-20240808","first-page":"1848","article-title":"Hepatitis C, collagenous colitis, and dermatomyositis occurring in the same patient.","volume":"97","author":"Germany","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R83-2-20240808","first-page":"240","article-title":"Autoimmune thrombocytopenic purpura and dermatomyositis associated with chronic hepatitis C. A therapeutic dilemma.","volume":"13","author":"Moccia","year":"1998","journal-title":"Ann Ital Med Int"},{"key":"R84-2-20240808","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1253\/jcj.64.617","article-title":"Hepatitis C virus infection in a patient with dermatomyositis and left ventricular dysfunction.","volume":"64","author":"Nakamura","year":"2000","journal-title":"Jpn Circ J"},{"key":"R85-2-20240808","first-page":"1845","article-title":"Hepatitis C and inclusion body myositis.","volume":"91","author":"Alexander","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"R86-2-20240808","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1600-0676.2001.210509.x","article-title":"Inclusion body myositis associated with hepatitis C virus infection.","volume":"21","author":"Kase","year":"2001","journal-title":"Liver"},{"key":"R87-2-20240808","first-page":"370","article-title":"Inclusion body myositis associated with hepatitis C virus infection.","volume":"92","author":"Tsuruta","year":"2001","journal-title":"Fukuoka Igaku Zasshi"},{"key":"R88-2-20240808","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1212\/01.WNL.0000133411.10574.BA","article-title":"Interferon beta-responsive inclusion body myositis in a hepatitis C virus carrier.","volume":"63","author":"Yakushiji","year":"2004","journal-title":"Neurology"},{"key":"R89-2-20240808","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2169\/internalmedicine.39.176","article-title":"Necrotizing myopathy in a patient with chronic hepatitis C virus infection: a case report and a review of the literature.","volume":"39","author":"Satoh","year":"2000","journal-title":"Int Med"},{"key":"R90-2-20240808","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000008097","article-title":"Detection of HCV-specific sequences in chronic myopathy with hepatitis C: improvement with interferon-alpha 2A therapy.","volume":"42","author":"Sola","year":"1999","journal-title":"Eur Neurol"},{"key":"R91-2-20240808","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1683","article-title":"Idiopathic pulmonary fibrosis and hepatitis C virus infection.","volume":"148","author":"Irving","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"R92-2-20240808","first-page":"38","article-title":"Hepatitis C and rheumatic diseases.","volume":"15","author":"Rull","year":"1998","journal-title":"J Muskuloskelet Med"},{"key":"R93-2-20240808","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/art.1780400232","article-title":"Dermatomyositis, hepatocellular carcinoma, and hepatitis C: comment on the article by Weidensaul et al.","volume":"40","author":"Gomez","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R94-2-20240808","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1365-2133.2001.04040.x","article-title":"Acquired ichthyosis associated with dermatomyositis in a patient with hepatocellular carcinoma.","volume":"144","author":"Inuzuka","year":"2001","journal-title":"Br J Dermatol"},{"key":"R95-2-20240808","first-page":"834","article-title":"Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma.","volume":"27","author":"Kee","year":"2004","journal-title":"Chang Gung Med J"},{"key":"R96-2-20240808","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3748\/wjg.v12.i10.1641","article-title":"Dermatomyositis associated with hepatocellular carcinoma in an elderly female patient with hepatitis C virus-related liver cirrhosis.","volume":"12","author":"Toshikuni","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R97-2-20240808","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1046\/j.1440-1746.2002.t01-1-02851.x","article-title":"Dermatomyositis and erythrocytosis in a patient with hepatocellular carcinoma.","volume":"17","author":"Cheng","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R98-2-20240808","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00296-008-0718-1","article-title":"Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma.","volume":"29","author":"Kee","year":"2009","journal-title":"Rheumatol Int"},{"key":"R99-2-20240808","first-page":"227","article-title":"Aberrant serum enzyme patterns in dermatomyositis associated with hepatoma.","volume":"3","author":"Gray","year":"1976","journal-title":"J Rheumatol"},{"key":"R100-2-20240808","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1440-1746.1989.tb00812.x","article-title":"Combined hepatocellular-cholangiocarcinoma associated with dermatomyositis.","volume":"4","author":"Horie","year":"1989","journal-title":"J Gastroenterol Hepatol"},{"key":"R101-2-20240808","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1182\/blood.V82.12.3701.3701","article-title":"Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia.","volume":"82","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"R102-2-20240808","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2362.1993.tb00782.x","article-title":"Hepatitis C virus and mixed cryoglobulinema.","volume":"23","author":"Ferri","year":"1993","journal-title":"Eur J Clin Invest"},{"key":"R103-2-20240808","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","article-title":"Type I interferons (alpha\/beta) in immunity and autoimmunity.","volume":"23","author":"Theofilopoulos","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R104-2-20240808","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/304177a0","article-title":"Myositis autoantibody inhibiting histidyl-tRNA synthetase: a model for autoimmunity.","volume":"304","author":"Mathews","year":"1983","journal-title":"Nature"},{"key":"R105-2-20240808","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1128\/JVI.72.5.3691-3697.1998","article-title":"Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1and enhances TNF-induced apoptosis.","volume":"72","author":"Zhu","year":"1998","journal-title":"J Virol"},{"key":"R106-2-20240808","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.1840210119","article-title":"Serum hepatocyte growth factor levels in liver diseases: clinical implications.","volume":"21","author":"Shiota","year":"1995","journal-title":"Hepatology"},{"key":"R107-2-20240808","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jcp.1041650211","article-title":"Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro.","volume":"165","author":"Allen","year":"1995","journal-title":"J Cell Physiol"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00131402-201109000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T23:14:51Z","timestamp":1723158891000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00131402-201109000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0b013e3181d4a527","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}